SCHEMBL107126

SCHEMBL107126

CN1C(=O)c2ccccc2S1(=O)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 13/20 1.00
CA2 P00918 5/20 1.00
CA12 O43570 13/20 0.61
ELANE P08246 2/20 0.56
HSD11B1 P28845 1/20 0.56
LMNA P02545 1/20 0.53
ALDH1A1 P00352 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30339085 1.00 CA9 (1.00) CA9CA2CA12ELANEHSD11B1
SCHEMBL13818597 0.81 CA9 (0.67) CA9CA2CA12ELANEHSD11B1
SCHEMBL29151571 0.78 ELANE (0.78) CA9CA2CA12ELANELMNA
SCHEMBL14294228 0.78 CYP2C9 (0.64) CA9CA2CA12HSD11B1LMNA
SCHEMBL10033197 0.78 CA9 (0.63) CA9CA2CA12ELANEHSD11B1
SCHEMBL20172048 0.77 CA9 (0.62) CA9CA2CA12ELANEHSD11B1
SCHEMBL19194634 0.77 CA9 (0.62) CA9CA2CA12HSD11B1LMNA
SCHEMBL13402635 0.76 CA9 (0.61) CA9CA2CA12ELANEHSD11B1
SCHEMBL698407 0.76 CA9 (1.00) CA9CA2CA12ELANEALDH1A1
SCHEMBL18537353 0.76 CA9 (0.61) CA9CA2CA12ELANEHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111825364-B Preparation method of environment-friendly naphthalene water reducer 安徽鑫固环保股份有限公司 2022-06-14 CN claimed
EP-1920010-B1 PROCESS FOR PREPARATION OF A NOVEL PIGMENTED COMPOSITION FOR USE IN GRAVURE INKS BASF SE (DE) 2013-01-16 EP claimed
US-8152915-B2 Process for preparation of a novel pigmented composition for use in gravure inks BASF SE (DE) 2012-04-10 US claimed
US-20090137706-A1 Process for preparation of a novel pigmented composition for use in gravure inks CIBA CORPORATION 2009-05-28 US claimed
EP-1920010-A2 PROCESS FOR PREPARATION OF A NOVEL PIGMENTED COMPOSITION FOR USE IN GRAVURE INKS Ciba SC Holding AG (CH) 2008-05-14 EP claimed
WO-2007025932-A2 PROCESS FOR PREPARATION OF A NOVEL PIGMENTED COMPOSITION FOR USE IN GRAVURE INKS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-03-08 WO claimed
EP-1274781-B1 POLYCARBONATE COMPOSITION RESISTANT TO GAMMA RADIATION BAYER AG (US) 2004-12-15 EP claimed
EP-0742260-B1 (Co)polycarbonates stabilized against gamma-rays BAYER AG (DE) 2000-07-05 EP claimed
US-5684062-A MOLDING MATERIALS WITH STABILIZATION TO RADIATION BAYER AG (DE) 1997-11-04 US claimed
JP-5255287-A None JP disclosed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
CN-121698822-A Preparation method of 5-methanesulfonyl amino methyl saccharin 遵义医科大学 2026-03-20 CN disclosed
US-20250290216-A1 PLATING FILM MANUFACTURING METHOD OKUNO CHEMICAL INDUSTRIES CO., LTD. (JP) 2025-09-18 US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 EP disclosed
EP-0085324-A2 Nylon compositions and rim process for making same The B.F. GOODRICH Company (US) 1983-08-10 EP disclosed
EP-0076643-A1 Processes for preparing piroxicam and intermediates leading thereto PFIZER INC. (US) 1983-04-13 EP disclosed
EP-0076643-A1 Processes for preparing piroxicam and intermediates leading thereto PFIZER INC. (US) 1983-04-13 EP disclosed
US-4376204-A 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam PFIZER INC. (US) 1983-03-08 US disclosed
US-4376204-A 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam PFIZER INC. (US) 1983-03-08 US disclosed
EP-0061434-A1 Derivatives of 2-amino-5-(o-sulphamidophenyl)-1,3,4-thiadiazole as antiviral agents and a process for the preparation thereof Società Italo-Britannica L. Manetti - H. Roberts & C. (IT) 1982-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL CA9 1611/4885CA2 3201/4885CA12 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.